SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BIOLARGO, INC. (BLGO) (CIK 0000880242) (BLGO) — Dec 9, 2015

BIOLARGO, INC. (BLGO) (CIK 0000880242)
Date: Dec. 9, 2015 · CIK: 0000880242 · Accession: 0000000000-15-057060

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
December 31, 2014
Author
/s/ John Cash
Form
UPLOAD
Company
BIOLARGO, INC. (BLGO) (CIK 0000880242)

Letter

December 9 , 2015 Mail Stop 4631 Via Facsimile Mr. Charles K. Dargan II Chief Financial Officer BioLargo, Inc. 3500 W. Garry Avenue Santa Ana, CA 92704

RE: BioLargo, Inc. Form 10 -K for the Year ended December 31, 2014 Filed March 31, 2015 File No. 0 -19709

Dear Mr. Dargan:

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ John Cash

Show Raw Text
December 9 , 2015

Mail Stop 4631

Via Facsimile
Mr. Charles K. Dargan II
Chief Financial Officer
BioLargo, Inc.
3500 W. Garry Avenue
Santa Ana, CA  92704

RE: BioLargo, Inc.
Form 10 -K for the Year ended December 31, 2014
Filed March 31, 2015
  File No. 0 -19709

Dear Mr. Dargan:

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ John Cash

 John Cash
Accounting Branch Chief
Office of Manufacturing and
Construction